We are live on ! Find out more
LAB icon

Standard BioTools

98 hedge funds and large institutions have $182M invested in Standard BioTools in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 21

1% more funds holding

Funds holding: 9798 (+1)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

26% less capital invested

Capital invested by funds: $246M → $182M (-$63.8M)

64% less call options, than puts

Call options by funds: $126K | Put options by funds: $349K

Holders
98
Holders Change
+1
Holders Change %
+1.03%
% of All Funds
2.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
34
Reduced
21
Closed
13
Calls
$126K
Puts
$349K
Net Calls
-$223K
Net Calls Change
-$204K
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$1.08M
BIM
27
BlackRock Investment Management
Delaware
$942K +$70.6K +7,689 +7%
Charles Schwab
28
Charles Schwab
California
$759K +$40.2K +4,372 +5%
Principal Financial Group
29
Principal Financial Group
Iowa
$626K +$7.44K +810 +1%
Deutsche Bank
30
Deutsche Bank
Germany
$625K -$1.83M -199,690 -72%
Jennison Associates
31
Jennison Associates
New York
$529K -$35.5K -3,867 -6%
Ohio Public Employees Retirement System (OPERS)
32
Ohio Public Employees Retirement System (OPERS)
Ohio
$518K
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$492K +$3.67K +400 +0.7%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$464K +$102K +11,100 +24%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$455K -$37.7K -4,100 -7%
Arrowstreet Capital
36
Arrowstreet Capital
Massachusetts
$416K +$477K +51,901 New
TA
37
Teachers Advisors
New York
$402K
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$368K
Swiss National Bank
39
Swiss National Bank
Switzerland
$336K
AllianceBernstein
40
AllianceBernstein
Tennessee
$333K
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$308K
CS
42
Credit Suisse
Switzerland
$269K -$2.19K -239 -0.7%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$268K +$3.31K +360 +1%
PP
44
PDT Partners
New York
$242K -$141K -15,400 -34%
WMSA
45
Weiss Multi-Strategy Advisers
New York
$240K +$74.7K +8,130 +37%
Citadel Advisors
46
Citadel Advisors
Florida
$237K +$272K +29,641 New
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$220K
SIP
48
Stoneridge Investment Partners
Pennsylvania
$194K -$1.06K -116 -0.5%
FPC
49
Falcon Point Capital
California
$176K +$350K +38,057 New
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$175K -$3.56K -388 -2%

LAB Hedge Fund Activity: Q3 2016 in Review

98 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2016, worth a combined $182M — down 26% from $246M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LAB positions and 13 closed out — a net gain of 1 holder — while 34 added to existing stakes and 21 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $7.25M. The largest seller was Columbia Wanger Asset Management, exiting entirely with an estimated $16M sold.

  • 98 institutional investors held Standard BioTools (LAB) as of Q3 2016, up from 97 in Q2 2016.
  • Funds reported $182M of Standard BioTools stock for Q3 2016, down 26% quarter-over-quarter.
  • 14 funds opened new Standard BioTools positions in Q3 2016 and 13 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q3 2016 was Levin Capital Strategies, an estimated $7.25M added.
  • The largest Standard BioTools seller in Q3 2016 was Columbia Wanger Asset Management, an estimated $16M sold.

Based on aggregated 13F filings for Q3 2016.